Publikationen, an denen er mitarbeitet Pedro Zapater Hernández (14)

2022

  1. Factors associated with lesion detection in colonoscopy among different indications

    United European Gastroenterology Journal, Vol. 10, Núm. 9, pp. 1008-1019

  2. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

    Frontiers in Medicine, Vol. 9

  3. Risk of Colorectal Cancer and Advanced Polyps One Year after Excision of High-Risk Adenomas

    Diseases of the Colon and Rectum, Vol. 65, Núm. 9, pp. 1112-1120

2020

  1. Risk of cancer in family members of patients with lynch-like syndrome

    Cancers, Vol. 12, Núm. 8, pp. 1-12

  2. Variation in Colonoscopy Performance Measures According to Procedure Indication

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 5, pp. 1216-1223.e2

2018

  1. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy

    PLoS ONE, Vol. 13, Núm. 9

  2. Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox

    United European Gastroenterology Journal, Vol. 6, Núm. 4, pp. 622-629

2017

  1. Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives

    Gastroenterology, Vol. 153, Núm. 1, pp. 106-112.e2

2016

  1. Endoscopist characteristics that influence the quality of colonoscopy

    Endoscopy, Vol. 48, Núm. 3, pp. 241-247

2013

  1. Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies

    Gastrointestinal Endoscopy, Vol. 77, Núm. 3

  2. Risk of cancer in cases of suspected lynch syndrome without germline mutation

    Gastroenterology, Vol. 144, Núm. 5

2011

  1. 5-fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer

    Gastroenterology, Vol. 140, Núm. 4, pp. 1174-1181

2009

  1. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status

    European Journal of Cancer, Vol. 45, Núm. 3, pp. 365-373

2006

  1. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer

    Gut, Vol. 55, Núm. 6, pp. 848-855